Orberg P K, Schaffer P A
J Virol. 1987 Apr;61(4):1136-46. doi: 10.1128/JVI.61.4.1136-1146.1987.
To minimize the contribution of residual activity associated with the temperature-sensitive (ts) form of ICP8 specified by available ts mutants, deletion mutations in this gene were constructed. Cells permissive for the generation and propagation of ICP8 deletion mutants were first obtained. Vero cells were cotransfected with pKEF-P4, which contains the gene for ICP8, and pSV2neo or a hybrid plasmid containing the G418 resistance gene linked to pKEF-P4. Of the 48 G418-resistant cell lines, 21 complemented ICP8 ts mutants in plaque assays at the nonpermissive temperature. Four of these were examined by Southern blot analysis and shown to contain 1 to 3 copies of the ICP8 gene per haploid genome equivalent. Cell line U-47 was used as the permissive host for construction of ICP8 deletion mutants. In addition to cell lines which complemented ts mutants, two lines, U-27 and U-35, significantly inhibited plaque formation by wild-type virus, contained 30 and 100 copies of the ICP8 gene per haploid genome equivalent, respectively, and expressed large amounts of ICP8 after infection with wild-type virus. At low but not high multiplicities of infection, this inhibition was accompanied by underproduction of viral polypeptides of the early, delayed-early, and late kinetic classes. For construction of deletion mutants, a 780-base-pair XhoI fragment was deleted from pSG18-SalIA, a plasmid which contains the gene for ICP8, to yield pDX. U-47 cells were then cotransfected with pDX and infectious wild-type DNA. Mutant d61, isolated from the progeny of cotransfection, was found to contain both the engineered deletion in the ICP8 gene and an oriL-associated deletion of approximately 55 base pairs. Because d61 contained two mutations, a second mutant, d21, which carried the engineered ICP8 deletion but an intact oriL, was constructed by cotransfection of U-47 cells with wild-type DNA and an SalI-KpnI fragment purified from pDX. Phenotypic analysis of d21 and d61 revealed that they were similar in all properties examined: both exhibited efficient growth in U-47 cells but not in Vero cells; both induced the synthesis of an ICP8 polypeptide which was smaller than the wild-type form of the protein and which, unlike the wild-type protein, was found in the cytoplasm and not the nucleus of infected Vero cells; and nonpermissive Vero cells infected with either mutant failed to express late viral polypeptides.
为了将与现有温度敏感(ts)突变体所指定的ICP8的温度敏感形式相关的残余活性的影响降至最低,构建了该基因的缺失突变体。首先获得了允许ICP8缺失突变体产生和增殖的细胞。将含有ICP8基因的pKEF-P4与pSV2neo或含有与pKEF-P4相连的G418抗性基因的杂交质粒共转染到Vero细胞中。在48个G418抗性细胞系中,有21个在非允许温度下的噬斑试验中能互补ICP8 ts突变体。通过Southern印迹分析检查了其中4个,结果显示每个单倍体基因组当量含有1至3个ICP8基因拷贝。细胞系U-47用作构建ICP8缺失突变体的允许宿主。除了能互补ts突变体的细胞系外,U-27和U-35这两个细胞系能显著抑制野生型病毒的噬斑形成,每个单倍体基因组当量分别含有30和100个ICP8基因拷贝,并且在感染野生型病毒后能大量表达ICP8。在低感染复数但不是高感染复数时,这种抑制伴随着早期、延迟早期和晚期动力学类别的病毒多肽产生不足。为了构建缺失突变体,从含有ICP8基因的质粒pSG18-SalIA中删除了一个780碱基对的XhoI片段,得到pDX。然后将pDX与感染性野生型DNA共转染到U-47细胞中。从共转染后代中分离出的突变体d61被发现既含有ICP8基因中的工程缺失,又含有一个与oriL相关的约55个碱基对的缺失。由于d61含有两个突变,通过将U-47细胞与野生型DNA和从pDX中纯化的SalI-KpnI片段共转染,构建了第二个突变体d21,它携带工程化的ICP8缺失但oriL完整。对d21和d61的表型分析表明,它们在所检查的所有特性上都相似:两者在U-47细胞中生长良好,但在Vero细胞中不能生长;两者都诱导合成一种比野生型蛋白小的ICP8多肽,并且与野生型蛋白不同,在感染的Vero细胞的细胞质中而不是细胞核中发现这种多肽;用任何一种突变体感染非允许的Vero细胞都不能表达晚期病毒多肽。